Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News Feature articles General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide News In Focus Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

Challenges ahead for China's Essential Drug Pricing Policy - Some Observations a... To help understand the overall dynamics surrounding recent essential drug pricing and timely present industry's views, Vivian Chen of RDPAC and James Shen of Pharma China... (8/30/2010) How much next-generation health IT will be made in China (External) (9/1/2010) Aligning China's Drug Safety & Quality Control Assessment System with Its Proposed New Pricing Mechanism (8/30/2010) Challenges ahead for China's Essential Drug Pricing Policy - Some Observations and Suggestions (8/30/2010) Pharma Industry under Pressure with Healthcare Reform in Deep Water (8/27/2010) Will China Lose Its Cost-Competitiveness In Pharma Manufacturing By 2015? (8/27/2010) IMS: Market Trends of the Chinese Hospital Drug Market MAT 1Q/2010 (8/25/2010) The PRC's New Tort Liability Law: What Can Pharmas Expect? (8/25/2010) New York Times: Chinese Hospitals Are Battlegrounds of Discontent (External) (8/12/2010) Asia-Pacific's March toward a New Drug Development Paradigm (External) (8/10/2010) Choosing Your General Manager for China (External) (8/3/2010) China: Behind the Screen (External) (7/30/2010) MOH releases Guidelines for Centralized Drug Purchase of Medical Institutions (with through summary) (7/23/2010) China's Pharma Market: Friend or Foe? (External) (7/19/2010) China issues new regulations on centralized hospital drug purchases (with full summary) (7/15/2010) Emerging Markets Under Anti-Corruption Microscope (7/15/2010) Discussions on DRG heat up as MOH readies reform of medical payment system  (9/3/2010) MOH begins random inspections of large hospitals  (9/3/2010) Survey shows outbreak of thyroid-related diseases in China  (9/3/2010) Eisai launches insulin secretagogue in China  (9/3/2010) Yangtze River Pharma to promote TCMs in the Netherlands  (9/3/2010) Emergent decides to back off from China following long wait for registration  (9/3/2010) IFPMA: Seasonal influenza vaccine distribution still below levels needed to meet guidelines  (9/3/2010) Roche initiates group-wide operational excellence initiative  (9/3/2010) IFPMA: Seasonal influenza vaccine distribution still bel... Roche initiates group-wide operational excellence initia... Reuters: Amgen on the prowl for international acquisitio... IMS: Accelerated growth for pharma industry between 2015... Taiwan pharma market generated US$3.9 bn in 2009 IMS announces top ten players of the Chinese hospital market in... Import and export of Western medicines rose sharply in the firs... New report: Chinese biopharma market to grow at 28% CAGR Chinese online pharmacy business undermined by illegal operatio... Chinese OTC cough, cold and allergy market posted strong growth... Eisai launches insulin secretagogue in China Yangtze River Pharma to promote TCMs in the Netherlands Emergent decides to back off from China following long wait ... Golden Helix and CloudScientific team up for SVS in China SinoPharm enters healthcare management business through JV w... Guangdong to electronically regulate most drug sales by ... USFDA head sees improving Chinese regulation of foods an... USFDA oversight of China-made APIs and drugs improved Pharma industry questions electronic regulation of essen... Harbin Yida Pharma ordered to recall injection product USDOJ and SEC investigate SciClone for potential FCPA violat... Merck under investigations for practices in foreign countrie... China and Taiwan signs bilateral agreement on IPR Chinese Tort Law went into effect on July 1 Three drug companies sue Chongqing Municipal Health Departme... Hisun to raise CNY 1.37 billion for expansion USFDA under pressure over Chinese heparin investigations... India to step up regulation of Chinese bulk drug imports... India bans API import from ten Chinese producers New steroid API manufacturing facility begins operation ... Lotus Pharma initiates phase I trial for R-Bambuterol Chinese scientists develop experimental vaccine against ... Study: Chinese herbal medicine may help chemotherapy pai... New data at China Heart Congress: expensive new blood pr... Stella pharma gains Chinese and U.S. patents for IC/PBS ... Discussions on DRG heat up as MOH readies reform of medi... MOH begins random inspections of large hospitals Survey shows outbreak of thyroid-related diseases in Chi... 100 Million Chinese children to receive measles innocula... New study: Chinese kidney problems linked to genes SFDA appoints director of China Pharmaceutical Publishing ... Frontier Healthcare Communications appoints general manage... Renhuang pharma appoints interim CFO Wuxi PharmaTech appoints new CFO New GM appointed for Roche China Upcoming Event: 4th Annual BioPharma Asia Convention 201... Discovery agrees to acquire 20% stake in Ping An Health ... Upcoming Event: Drug Discovery and Development, from Dis... Upcoming Event: ADME PK/TK and Drug Metabolism in Drug D... China keen to develop commercial health insurance as a p... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON publishes China Pharmace...   Pharma China adds one more dis...   WiCON Launches China Pharmaceu...   Pharma China adds another dist...   Testimonials from subscribers ...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links